Home > Insider Trading > Filing (0001209191-19-034749)

Filing Details

Accession Number:: 0001209191-19-034749
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2019-06-05 16:33:51
Reporting Period:: 2019-06-03

Accepted Time:: 2019-06-05 16:33:51
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1645113	Novocure Ltd	NVCR	Surgical & Medical Instruments & Apparatus (3841)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1654363	J. Michael Ambrogi	C/O Novocure Inc. 20 Valley Stream Parkway, Suite 300 Malvern PA 19355	Chief Operating Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Ordinary Shares	Acquisiton	2019-06-03	17,500	$7.15	203,174	No	4	M	Direct
Ordinary Shares	Disposition	2019-06-03	16,700	$52.09	186,474	No	4	S	Direct
Ordinary Shares	Disposition	2019-06-03	800	$52.70	185,674	No	4	S	Direct
Ordinary Shares	Acquisiton	2019-06-04	17,500	$7.15	203,174	No	4	M	Direct
Ordinary Shares	Disposition	2019-06-04	17,300	$53.11	185,874	No	4	S	Direct
Ordinary Shares	Disposition	2019-06-04	200	$53.79	185,674	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Ordinary Shares	Options to Buy Ordinary Shares	Disposition	2019-06-03	17,500	$0.00	17,500	$7.15
Ordinary Shares	Options to Buy Ordinary Shares	Disposition	2019-06-04	17,500	$0.00	17,500	$7.15

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
144,013		2027-02-21	No	4	M	Direct
126,513		2027-02-21	No	4	M	Direct

Footnotes

Transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi.
On June 3, 2019, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi, Mr. Ambrogi sold 16,700 shares in multiple trades at prices ranging from $51.64 to $52.63. The price reported above reflects the weighted average sale price. Mr. Ambrogi hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
On June 3, 2019, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi, Mr. Ambrogi sold 800 shares in multiple trades at prices ranging from $52.65 to $52.83. The price reported above reflects the weighted average sale price. Mr. Ambrogi hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
On June 4, 2019, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi, Mr. Ambrogi sold 17,300 shares in multiple trades at prices ranging from $52.73 to $53.70. The price reported above reflects the weighted average sale price. Mr. Ambrogi hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
On June 4, 2019, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi, Mr. Ambrogi sold 200 shares in multiple trades at prices ranging from $53.74 to $53.84. The price reported above reflects the weighted average sale price. Mr. Ambrogi hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
Fully vested as of the date hereof.